Shimadzu Journal vol.8 Issue1
Ostatní | 2020 | ShimadzuInstrumentace
GC/MSD, GC/MS/MS, GC/QQQ, HPLC, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC/QQQ, SFC, PrepLC
ZaměřeníFarmaceutická analýza
VýrobceShimadzu
Klíčová slovasfc, pharmaceutical, ndma, shimadzu, metformin, hydroxychloroquine, preparative, insight, team, customer, project, etc, members, providence, instrument, antibody, development, participating, sulfate, new, features, cancer, pump, impurity, prep, from, nexera, report, drug, ranitidine, scale, biba, mirlinda, nmu, monoclonal, fraction, test, technologies, purifications, states, impurities, instruments, user, enabling, hydrochloride, tablets, medicinal, industry, peak, genotoxic
Podobná PDF
Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances -
2020|Shimadzu|Příručky
Application Note No. 62 Analysis of Pharmaceuticals’ Impurity - Regulations and Analysis for Carcinogenic Substances Dheeraj Handique *a), Nitish Suryawanshi *a), Crystal Yeong *b), Cynthia Lahey *b), Shailendra Rane *a), Deepti Bhandarkar *a), Anant Lohar *a), Gao Jie san *c),…
Klíčová slova
ndma, ndmandea, ndeacarcinogenic, carcinogenicsubstances, substancesmutagenic, mutagenicmms, mmsems, emsimpurity, impuritymode, modeims, imsdrug, drugmutagenicity, mutagenicityolmesartan, olmesartanndba, ndbapharmaceuticals
Detection and Quantitation of NDMA Impurity in Ranitidine Drug Substances and Products by LC-HRMS on LCMS-9030
2021|Shimadzu|Aplikace
NDMA impurity in Ranitidine / LCMSTM-9030 Application News Detection and Quantitation of NDMA Impurity in Ranitidine Drug Substances and Products by LC-HRMS on LCMS-9030 Zhe Sun and Zhaoqi Zhan User Benefits Determination of NDMA in ranitidine API and drug…
Klíčová slova
ndma, ndmaranitidine, ranitidinedrug, drugsubstance, substanceanalyzed, analyzedinjection, injectionproducts, productsexcept, excepthrms, hrmsapi, apizhe, zhesuspend, suspendzhan, zhanimpurity, impurityzhaoqi
Nitrosamine Impurities Application Guide - Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products
2020|Agilent Technologies|PříručkyPrezentace
Nitrosamine Impurities Application Guide Confidently Detect and Quantify Mutagenic Impurities in APIs and Drug Products Sartan-Based Losartan Valsartan Candesartan Telmisartan Metformin Ranitidine Nitrosamines are formed by chemical reactions that occur during API manufacturing whether from starting materials, intermediates, reactants, reuse…
Klíčová slova
back, backndma, ndmaneipa, neipafda, fdandea, ndeandipa, ndipandba, ndbametformin, metforminnitrosamine, nitrosamineintroduction, introductionapi, apivalsartan, valsartanquant, quantbest, bestcandesartan
Nitrosamine impurities analysis solution guide
2021|Thermo Fisher Scientific|Příručky
Nitrosamine impurities analysis solution guide • Find the right analytical solution for each stage of nitrosamine impurity analysis • Confidently detect and quantify genotoxic impurities in active pharmaceutical ingredients and finished drug products Table of contents Monitoring genotoxic impurities in…
Klíčová slova
nitrosamine, nitrosaminepage, pagehram, hramcontents, contentsnext, nextimpurity, impurityback, backresources, resourceslearn, learnmetformin, metforminsoftware, softwarevalsartan, valsartanthermo, thermosolution, solutionmass
